J J FINKELSTEIN Insider Profile
4 Followers
J J FINKELSTEIN, President & CEO, Director at RegeneRx Biopharmaceuticals, holds 1.71M shares in RegeneRx Biopharmaceuticals (Ticker: RGRX). Most recently, J J FINKELSTEIN Bought 75,000 shares of RegeneRx Biopharmaceuticals on Jul 06, 2021 for an estimated value of $15.00K.
J J FINKELSTEIN's Trading History
| RGRXRegeneRx Biopharmaceuticals | Jul 06, 2021 | President & CEO, Director | Informative Buy | 15.00K | $296.35K | |
You May Also Like
J J FINKELSTEIN insider profile FAQ
What is the percentage of profitable transactions made by J J FINKELSTEIN?
The percentage of profitable transactions made by J J FINKELSTEIN is 0%.
What is the average return per transaction made by J J FINKELSTEIN?
The average return per transaction made by J J FINKELSTEIN is -37.60%.
What stocks does J J FINKELSTEIN hold?
J J FINKELSTEIN holds: RGRX stocks.
What was J J FINKELSTEIN’s latest transaction?
J J FINKELSTEIN’s latest transaction was an Informative Buy of $15.00K.
What was J J FINKELSTEIN's most profitable transaction?
J J FINKELSTEIN’s most profitable transaction was an Informative Buy of RGRX stock on July 9, 2018. The return on the trade was -21.10%.
What is J J FINKELSTEIN's role in RegeneRx Biopharmaceuticals?
J J FINKELSTEIN's role in RegeneRx Biopharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
